Epigenetics is challenging long-held notions that our genes are our destiny and radically changing the way researchers think about the development of certain illnesses. As science come to understand the way epigenetic processes silence genes, it is given rise to promising new therapies for diseases such as MDS. Watch The Journal of Life Sciences webcast featuring
ALLEN YANG, MD, PhD
Assistant Professor, Hematology
USC / Norris Comprehensive Cancer Center
Keck School of Medicine
ANDREW ALLEN, BM, BCh, MA, MRCP, PhD
Executive Vice President and
Chief Medical Officer
Pharmion Corporation
KATHY HEPTINSTALL, BSN, RN
Operating Director
The MDS Foundation
This webcast was made possible through underwriting from Pharmion.
Click here to view.
November 28, 2007
http://www.burrillreport.com/article-webcast.html